Arrowhead Enters Obesity Chat by Doubling Tirzepatide’s Weight Loss in Combo Study

Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and enhance weight loss as compared to tirzepatide alone, particularly in patients with type 2 diabetes.